Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 70,554 shares at $94.72 ($6.7M) on 2025-03-31, disclosed to the SEC on 2025-04-02.
Scheduled sale ($6.7M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.72 | 35,102 | $3.3M | 49.7% |
| 2 | $94.72 | 35,102 | $3.3M | 49.7% |
| 3 | $114.71 | 350 | $40K | 0.6% |
| Total | $94.82 avg | 70,554 | $6.7M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |